Health Inc. : Shots - Health News As spending on care rises, the business of health keeps getting more important. We feature news on and analysis of drugmakers, health insurers, hospitals, doctors and others in the business of providing health care.

Health Inc.

Tuesday

Wednesday

New research suggests that doctors who communicate online with their patients may not see a drop in office visits. iStockphoto.com hide caption

toggle caption
iStockphoto.com

Patients With Online Access To Doctors May Make More Office Visits

  • Download
  • <iframe src="https://www.npr.org/player/embed/165584353/165630330" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Dr. Wanda Simmons-Clemmons examines Dawn Antonelli at the PromptCare urgent care clinic. Jenny Gold for NPR hide caption

toggle caption
Jenny Gold for NPR

Hospitals Gamble On Urgent Care Clinics To Keep Patients Healthy

  • Download
  • <iframe src="https://www.npr.org/player/embed/164614170/164669186" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Tuesday

Wednesday

Tuesday

Wednesday

Tuesday

With help from the Affordable Care Act, government fraud investigators will make more use of computer programs to detect Medicare and Medicaid scams. iStockphoto.com hide caption

toggle caption
iStockphoto.com

Health Law Gives Medicare Fraud Fighters New Weapons

  • Download
  • <iframe src="https://www.npr.org/player/embed/158761170/159486357" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

Submitting a DNA sample to networking company 23andMe entails spitting a saliva sample into a plastic vial. 23andMe hide caption

toggle caption
23andMe

Search For Parkinson's Genes Turns To Online Social Networking

  • Download
  • <iframe src="https://www.npr.org/player/embed/158943097/159308716" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

Thursday

Tuesday

Monday

GlaxoSmithKline's mishandling of information on safety problems with diabetes drug Avandia is just one of the violations cited in a settlement with the government. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images